Chemical formula: C₁₇H₂₉GdN₄O₇ Molecular mass: 558.68 g/mol PubChem compound: 60714
Gadoteridol is indicated for:
Population group: only adults (18 years old or older)
Using Magnetic Resonance Imaging (MRI), gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood-brain barrier.
Gadoteridol can also be used for whole body MRI including the head, neck, liver, breast, muscoloskeletal system and soft tissue pathologies.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)
Using Magnetic Resonance Imaging (MRI), gadoteridol provides contrast enhancement of the brain, spine and surrounding tissues resulting in improved visualization (compared with unenhanced MRI) of lesions with abnormal vascularity or those thought to cause a disruption of the normal blood-brain barrier.
Gadoteridol can also be used for whole body MRI including the head, neck, liver, breast, muscoloskeletal system and soft tissue pathologies.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
